Healthcare Realty Trust stock forecast
Healthcare Realty Trust (HT0) Stock Forecast & Price Target
HT0 Analyst Ratings
HT0 Stock 12 Month Forecast
Average Price Target
€18.19▲(5.77% Upside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Michael Goldsmith | UBS | €16.27→€18.08 | hold | 5.11%Upside | Assigned | 11/11/26 | ||
| Nicholas Yulico | Scotiabank | €19.89 | buy | 15.62%Upside | Reiterated | 10/30/26 | ||
| Michael Gorman | BTIG | €19.89 | buy | 15.62%Upside | Reiterated | 10/29/26 | ||
| Omotayo Okusanya | Deutsche Bank | €20.79 | buy | 20.87%Upside | Upgraded | 10/20/26 | ||
| James Feldman | Wells Fargo | €18.08→€16.27 | hold | -5.40%Downside | Assigned | 10/19/26 | ||
| Michael Carroll | RBC Capital | €19.89 | hold | 15.62%Upside | Reiterated | 10/08/26 | ||
| Joe Dickstein | Jefferies | €18.08 | hold | 5.11%Upside | Reiterated | 09/15/26 | ||
| Paul Choi | Goldman Sachs | €12.66 | hold | -26.42%Downside | Reiterated | 08/16/26 | ||
| Richard Anderson | Cantor Fitzgerald | €19.89→€21.69 | buy | 26.13%Upside | Assigned | 07/31/26 | ||
| Michael Mueller | J.P. Morgan | €17.17→€18.98 | hold | 10.36%Upside | Reiterated | 07/09/26 | ||
| Dave Rodgers | Raymond James | €21.69 | buy | 26.13%Upside | Initiated | 06/16/26 | ||
| Nicholas Joseph | Citi | €17.17→€18.98 | hold | 10.36%Upside | Reiterated | 05/07/26 | ||
| Juan C. Sanabria | BMO Capital | €18.08 | hold | 5.11%Upside | Reiterated | 04/30/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Michael GoldsmithUBS | HoldAssigned€16.27→€18.08 | 11/11/26 | 5.11%Upside | ||
| Nicholas YulicoScotiabank | BuyReiterated€19.89 | 10/30/26 | 15.62%Upside | ||
| Michael GormanBTIG | BuyReiterated€19.89 | 10/29/26 | 15.62%Upside | ||
| Omotayo OkusanyaDeutsche Bank | BuyUpgraded€20.79 | 10/20/26 | 20.87%Upside | ||
| James FeldmanWells Fargo | HoldAssigned€18.08→€16.27 | 10/19/26 | -5.40%Downside | ||
| Michael CarrollRBC Capital | HoldReiterated€19.89 | 10/08/26 | 15.62%Upside | ||
| Joe DicksteinJefferies | HoldReiterated€18.08 | 09/15/26 | 5.11%Upside | ||
| Paul ChoiGoldman Sachs | HoldReiterated€12.66 | 08/16/26 | -26.42%Downside | ||
| Richard AndersonCantor Fitzgerald | BuyAssigned€19.89→€21.69 | 07/31/26 | 26.13%Upside | ||
| Michael MuellerJ.P. Morgan | HoldReiterated€17.17→€18.98 | 07/09/26 | 10.36%Upside | ||
| Dave RodgersRaymond James | BuyInitiated€21.69 | 06/16/26 | 26.13%Upside | ||
| Nicholas JosephCiti | HoldReiterated€17.17→€18.98 | 05/07/26 | 10.36%Upside | ||
| Juan C. SanabriaBMO Capital | HoldReiterated€18.08 | 04/30/26 | 5.11%Upside |
Best Analysts Covering Healthcare Realty Trust
Copying Richard Anderson's trades and holding each position for 3 Months would result in 58.33% of your transactions generating a profit, with an average return of -1.16% per trade.
Copying Michael Gorman's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +6.83% per trade.
Copying Michael Gorman's trades and holding each position for 2 Years would result in 75.00% of your transactions generating a profit, with an average return of +14.38% per trade.
HT0 Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 9 | 5 | 3 | 3 | 3 |
| Hold | 5 | 6 | 8 | 8 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 14 | 11 | 11 | 11 | 9 |
In the current month, HT0 has received 3 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. HT0 average Analyst price target in the past 3 months is 18.19.
HT0 Financial Forecast
HT0 Earnings Forecast
Next quarter’s earnings estimate for HT0 is EUR 0.01 with a range of -EUR 0.01 to EUR 0.08. The previous quarter’s EPS was -EUR 0.05. Its overall industry beat the EPS estimate 54.52% of the time in the past 12 months.
HT0 Sales Forecast
Next quarter’s sales forecast for HT0 is EUR 251.77M with a range of EUR 238.05M to EUR 260.29M. The previous quarter’s sales results were EUR 259.10M. Its overall industry beat sales estimates 73.09% of the time in the past 12 months.

